Edward Rebar Email Address

Senior Vice President and Chief Technology Officer

Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.

R&D executive with 15 years of leadership experience developing genome-targeting therapies and technologies. Adept at setting strategy and prioritizing resources for developing therapeutic candidates, with four products having reached clinical studies. Scientific leader with a record of impactful publications spanning 25 years. Effective at defining research directions that grow the enterprise while sparking broader interest. Deep knowledge of gene editing and related fields, including protein engineering, directed evolution, cell engineering and analytical genomics. Strong communicator, both across functions and to external stakeholders. Extensive experience presenting at scientific conferences and also in nonspecialist settings, including investor meetings, partnering discussions, collaborator updates, SAB meetings, and presentations to the Board. Hands-on leader equally comfortable discussing tactics and processes as with setting strategic direction. Effective mentor with a demonstrated ability to elicit transformative outcomes from scientific teams.